products

White Color Anti Pneumonia Drugs Remdesivir Powder With Cas 1809249-37-3

Basic Information
Place of Origin: CHINA
Brand Name: MOSINTER
Certification: COA
Model Number: Pneumonia Treatment Drugs - 2
Minimum Order Quantity: 25KGS
Price: Negotiation
Packaging Details: Aluminum foil bag , fiber can , kraft paper bag , plastic drum , 1kg/ bag or 25kg/ drum or as required
Delivery Time: Within 7 days
Payment Terms: T/T, Western Union
Supply Ability: 200-300 MTS/month
Detail Information
Name: Remdesivir CAS: 1809249-37-3
Form: Powder Molecular Formula: C27H35N6O8P
Molecular Weight: 602.575961 Type: Pneumonia Treatment Drugs

Product Description

Remdesivir CAS 1809249-37-3 Pneumonia Treatment Drugs

 

Description:

 

This product is white powder.

 

Recommended time: on February 6, with the support of the Ministry of science and technology, the national health and Health Commission, the State Food and Drug Administration and other departments, the antiviral drug remdesivir has completed the registration and approval of clinical trials, and the first group of cases has been put in place. At present, the drug is still in the clinical trial stage, and it is an unlisted new drug.

 

Expert evaluation: on January 24, Lu Hongzhou, Secretary of the Party committee of Shanghai public health clinical center, issued a document saying that, according to the current research data, radcivir may be the most potential anti crown drug.

 

Drug profile: readcivir is a broad-spectrum antiviral drug developed by Gilead, an American pharmaceutical company. This drug was originally developed for Ebola virus, but its effect is not so obvious. On the contrary, in vitro and in vivo animal models, it has proved the activity of radcivir to mers and SARS virus pathogens. The above two viruses are coronaviruses, similar to new coronavirus in structure, but whether radcivir will show any clinical activity to new coronavirus is not clear.

 

Reid Nelisiwe has shown novel coronavirus pneumonia in the United States and France. Currently, China Reed novel coronavirus 2019 phase III clinical trials are advancing in China.

 

Development stage: clinical trial stage. It is expected that the clinical trial of radcivir will produce results in April.

 

Specifications:

 

Appearance
White powder
Assay
99%min
Test
HPLC

 

Application:

 

It is a nucleoside analogue with antiviral activity. In hae cells, the EC50 value of SARS CoV and mers cov is 74 nm, in delayed brain tumor cells, the EC50 value of mouse hepatitis virus is 30 nm.

 

Our strengths:

 

We can customize according to customer's requirement.

If you have any question pls mail us or call us.

 

Contact Details
Fedor

Phone Number : +86 18989305995

WhatsApp : +18989305995